Literature DB >> 25120044

Awareness of and attitudes toward direct-to-consumer prescription drug advertising among young adults.

Neil M Alperstein1.   

Abstract

This study examines awareness and knowledge of and attitudes toward direct-to-consumer (DTC) prescription drug advertising among young adults between 18 and 24 years of age. The study finds that young adults are not as aware of prescription drug advertising as older consumers, however, they are aware of specific heavily advertised drugs, especially those for allergy medications, birth control, and sleep aids. Young adults hold mixed to negative views about advertising in general, and they do not view DTC prescription drug advertising as a beneficial source of information, nor do they believe such advertising serves to educate consumers.

Entities:  

Keywords:  awareness and attitudes; drug advertising; prescription drugs; youth marketing

Mesh:

Substances:

Year:  2014        PMID: 25120044     DOI: 10.1080/07359683.2014.936291

Source DB:  PubMed          Journal:  Health Mark Q        ISSN: 0735-9683


  4 in total

1.  Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration.

Authors:  Helen W Sullivan; Miriam Campbell
Journal:  J Health Commun       Date:  2015-06-29

2.  This should help with that: A behavioral investigation into self-derivation of knowledge about prescription medications.

Authors:  Jessica A Dugan; Patricia J Bauer
Journal:  Appl Cogn Psychol       Date:  2022-02-06

3.  Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration.

Authors:  Helen W Sullivan; Kathryn J Aikin; Eunice Chung-Davies; Michael Wade
Journal:  PLoS One       Date:  2016-05-05       Impact factor: 3.240

4.  A survey of perceptions and attitudes about direct-to-consumer advertising of prescription drugs among college students in South Korea.

Authors:  Young-Mo Yang; Jae-Joon Lee; Eun Jeong; Sun Young Kim; Mi Ah Han; Eun Joo Choi
Journal:  PLoS One       Date:  2018-07-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.